Lv3
288 积分 2022-07-20 加入
Immune-checkpoint inhibitors: long-term implications of toxicity
3小时前
待确认
Anlotinib plus benmelstobart and chemotherapy are effective in ES-SCLC
4个月前
已完结
[Interpretation of 5(th) edition WHO classification of pancreatic tumor]
5个月前
已完结
Therapeutic developments in pancreatic cancer
5个月前
已完结
Expression of claudins 7 and 18 in pancreatic ductal adenocarcinoma: association with features of differentiation
5个月前
已完结
Claudin-18 Immunohistochemical Staining Facilitates the Identification of Metastatic Carcinoma of Gastric or Pancreatic Origin in Effusion Specimens
5个月前
已完结
A first-in-human study of the fibroblast activation protein–targeted, 4-1BB agonist RO7122290 in patients with advanced solid tumors
6个月前
已完结
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
6个月前
已完结
Cancer incidence and mortality in China, 2022
8个月前
已完结
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
9个月前
已完结
皖公网安备34019202002308
